SSTR2 and neuroendocrine neoplasm: SSTR2 is a cell surface receptor overexpressed in neuroendocrine tumors [12–14] and peptide-based SSTR2-targeting, for example by radiolabeled DOTATATE, is already used for diagnostic imaging.